adnan-s 1

1. Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort
2. Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis
3. Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant Tuberculosis
1